BioSpace News Archive

Drug Development

AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis

AB Science SA announced that its Phase III clinical trial in progressive forms of multiple sclerosis has been approved by the US Food and Drug Administration.

December 29, 2022
·
7 min read
Policy

Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults

Vericel Corporation, a leader in advanced therapies for the sports medicine and severe burn care markets, announced that the U.S. Food and Drug Administration has approved NexoBrid® for the removal of eschar in adults with deep partial-thickness and/or full-thickness thermal burns.

December 29, 2022
·
7 min read
Business

Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company’s Board of Directors

Viatris Inc., a global healthcare company, announced that Scott A. Smith and Elisha W. Finney have been appointed as Viatris’ newest members of its board of directors.

December 29, 2022
·
7 min read
Business

OTC Markets Group Grants Evofem Additional Time to File Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2022

Evofem Biosciences, Inc. announced that it has been granted additional time by the OTC Markets Group to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.

December 29, 2022
·
1 min read
Kane Biotech Announces Loan Transaction

Kane Biotech Inc. announces that it has reached an agreement to obtain loans in the aggregate amount of $2,000,000 from two lenders.

December 29, 2022
·
3 min read
Policy

ABM Respiratory Care Announces the FDA Clearance of the BiWaze Clear System

ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced the U.S. Food and Drug Administration 510 clearance of the BiWaze® Clear System.

December 29, 2022
·
2 min read
Biotech Beach

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - December 29, 2022

Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgeons, announced that on December 27, 2022, the Company approved equity award grants under the Sientra Inc. Inducement Plan to 13 new employees.

December 29, 2022
·
1 min read
Business

Neuronetics Announces Appointment of Joseph H. Capper to its Board of Directors

Neuronetics, Inc. announced the appointment of Joseph H. Capper to its Board of Directors and as a member of the Audit Committee effective January 1, 2023.

December 29, 2022
·
4 min read
Deals

Disc Medicine Announces Completion of Merger with Gemini Therapeutics

Disc Medicine, Inc. announced that its previously-announced merger with Gemini Therapeutics, Inc. closed on December 29, 2022, following the approval of Gemini shareholders.

December 29, 2022
·
8 min read
Everest Medicines to Hold New Corporate Strategy Online Conference Calls

Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced that the Company’s management will host conference calls to introduce its new corporate strategy.

December 29, 2022
·
3 min read